Sacroiliac Joint Fusion is projected to Secure a Market Value of US$ 3,900 Million by 2032

The market for fusion of the sacroiliac joint is anticipated to reach US$ 620 million in 2022 and US$ 3,900 million in 2032. The market is anticipated to expand at a CAGR of 20.2% between 2022 and 2032.The market is growing as a result of the quick technological advancement in the healthcare industry and the rising demand for minimally invasive surgical treatments.

With the development of minimally invasive surgical methods, sacroiliac joint fusion (SIJF) has rapidly increased in popularity. As a result, the number of novel medical devices used for SIJF has skyrocketed. The demand for MIS sacroiliac joint fusion treatment is said to be fueled by the rising number of vehicle accidents that result in joint displacement.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7164?AS 

According to Fact.MR, North America will account for 42% of sales in 2022 and beyond. The region’s high share is due to the presence of key companies, modern healthcare infrastructure, and expanding reimbursement coverage. Also, a surge in joint pain is broadening growth potential.

According to the National Center for Biotechnology Information, the annual prevalence of low back pain among individuals in the United States ranges from 15% to 45%. Significant efforts have been made to better understand the many aetiologies of back pain in response to this disease load and in the hope of improving results. The SI joint, in particular, has recently received increased attention as a pain generator, with estimates of low back pain related to the SI joint ranging from 15% to 30%.

Key Takeaways:

• By 2022, sacroiliac joint fusion market to be valued at US$ 620 Mn
• Around 42% of global sacroiliac joint fusion market revenue to be contributed by North America
• Asia Pacific to experience lucrative growth, registering a 17% value CAGR until 2032
• By indication, degenerative sacroiliitis to accumulate 39% revenue share in 2022
• Sacroiliac joint fusion surgeries to account for 40% revenue in 2022 and beyond
• More than half of all sacroiliac joint fusion procedures to occur across hospitals

Growth Drivers

• The increasing adoption of minimally invasive surgeries is anticipated to be the key factor driving the market during the forecast period. Further, the improving diagnostic capabilities for sacroiliac joint disorders and the adoption of new technologies are likely to offer better SI joint fusion systems.
• In addition, the increasing geriatric population in developed countries like the US and the growing incidences of chronic diseases are anticipated to make a significant contribution in boosting the market. As per the 2019 data of the U.S Census Bureau, out of 328 million U.S population, about 75 million were 60 years and above.

Competitive Landscape:

The various leading players in the Sacroiliac joint fusion market focus on offering various marketing strategies adopted by key players such as mergers and acquisitions, expansions, collaborations, and partnerships.

• In September 2021, PainTEQ was granted 3 patents in the U.S. for its drill-less method of stabilizing an SI joint, abrading device used in the procedure, and allograft implant respectively. All three offerings are used in the company’s minimally invasive LinQ procedure for SI joint dysfunction, thus solidifying PainTEQ’s position in the market.
• In June 2020, Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D-printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction.

Key Companies Profiled by Fact.MR

• SI-BONE Inc.
• PainTEQ
• CornerLoc
• SIGNUS Medizintechnik GmbH
• Globus Medical
• Orthofix Medical Inc.
• Life Spine Inc.
• Camber Spine Technologies LLC
• CoreLink Surgical
• Xtant Medical
• Surgalign Spine Technologies Inc.
• Medtronic Plc.

Key Segments Covered in the Sacroiliac Joint Fusion Market Report

• By Indication :
  • Joint Fusion for Degenerative Sacroiliitis
  • Joint Fusion for Sacral Disruption
  • Sacroiliac Joint Fusion for Trauma
• By Treatment Type :
  • Sacroiliac Joint Fusion Surgery
    • Surgery Type
      • Minimally Invasive Sacroiliac Joint Fusion Surgery
      • Open Sacroiliac Joint Fusion Surgery
    • Approach
      • Dorsal Sacroiliac Joint Fusion
      • Anterior Sacroiliac Joint Fusion
    • Product
      • Sacroiliac Joint Fusion Implants
      • Sacroiliac Joint Fusion Accessories
  • Sacroiliac Joint Fusion Injections
    • Diagnosis
    • Treatment
  • RF Sacroiliac Joint Fusion Ablation
• By End User :
  • Sacroiliac Joint Fusion in Hospitals
  • Sacroiliac Joint Fusion in Ambulatory Surgical Centers
  • Sacroiliac Joint Fusion for Other End Users (Specialty Centers and Research & Academic Institutes)

Get Full Access of Complete Report:
https://www.factmr.com/checkout/7164

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : [email protected]